Long Term Oral Etoposide As Second-Line Therapy In Recurrent Epithelial Carcinoma Of The Ovary
Background: The activity and toxicity of etoposide in women with recurrent ovarian cancer was evaluated in a case series of women with recurrent ovarian cancer who had measurable disease, Methods: All patients had plior platinum-based chemotherapy and developed progressive disease, Etoposide was giv...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Iran University of Medical Sciences
2005-01-01
|
Series: | Medical Journal of The Islamic Republic of Iran |
Subjects: | |
Online Access: | http://mjiri.tums.ac.ir/browse.php?a_id=1602&slc_lang=en&sid=1&ftxt=1 |